Director, Regulatory Affairs – AWB
Smith and Nephew
This listing was originally posted on Smith and Nephew's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moLife Unlimited. At Smith+Nephew we design and manufacture technology that takes the limits off living. Reporting to the Senior Vice President Global Regulatory Affairs and Commercial Quality the Director Regulatory Affairs Wound will develop and implement global regulatory strategies in support of business objectives, provide strong leadership to their regulatory team and other cross functional team members.
What will you be doing?
- The Director will lead the regulatory strategy for the Advanced Wound Bioactives (AWB) portfolio of products that include Sec 351 regulated Biologic products, Sec 361 regulated Human Cells, Tissues, and Cellular and Tissue- Based products (HCT/P) as well supporting the NPD portfolio of device-led combination products.
- Responsible for leading a regulatory team spread across two locations (Fort Worth, TX and Columbia, MD). This includes developing and mentoring the RA department to build an effective and efficient responsive team.
- Lead the regulatory team in development of regulatory strategies for 510(k), sBLA and Health Canada submission and approvals.
- Participate and support FDA audits/inspections to maintain all necessary certifications/approvals and ensure compliance with applicable regulations.
- Champions a culture of collaboration, leadership, mutual accountability, critical thinking and continuous improvement within a high-performing team. Represents Regulatory Affairs with excellence in cross-functional interactions and represent Business RA with excellence in interactions with regional RA representatives.
- Responsible for assuring compliance with all relevant laws and regulations, domestic and international.
What will you need to be successful?
- Minimum Bachelor's degree in Sciences, Engineering or equivalent.
- A minimum of ten years' regulatory experience required
- Proven experience in leading FDA BLA and sBLA CMC submissions and FDA medical device submissions including 510(k)'s and Q-subs.
- Experience and knowledge on Sec 361 regulated Human Cells, Tissues, and Cellular and Tissue-Based products (HCT/P) highly desired.
- In-depth experience in dealing with FDA and international medical device regulatory agencies.
- Expert regulatory knowledge within relevant therapy area (Biologics, HCT/P's and device-led combination products)
- Ability to work strategically within complex, business critical and high-profile programs.
- Ability to think strategically and critically evaluate risks to regulatory activities.
- Must demonstrate strategic thinking with ability to influence, strong initiative, work ethic and excellent oral and written communication skills.
You Unlimited.
Smith+Nephew provides equal employment opportunities to applicants and employees without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability.
Stay connected by joining our Talent Community.
We're more than just a company - we're a community! Follow us on LinkedIn to see how we support and empower our employees and patients every day.
Check us out on Glassdoor for a glimpse behind the scenes and a sneak peek into You. Unlimited., life, culture, and benefits at S+N.
Explore our website and learn more about our mission, our team, and the opportunities we offer.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Smith and Nephew?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Sports Medicine, Trauma, Wound Care, etc.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo